Creating a functional opioid alkaloid binding site in the orphanin FQ receptor through site-directed mutagenesis

Molecular Pharmacology

Volumn 53, Issue 4, 1998, Pages 772-777

  Meng, Fan ^a   Ueda, Yasuko ^a   Hoversten, Mary T ^a   Taylor, Larry P ^a   Reinscheid, Rainer K ^b   Monsma, Frederick J ^b   Watson, Stanley J ^a   Civelli, Olivier ^b   Akil, Huda ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

^b F HOFFMANN LA ROCHE LTD   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

BREMAZOCINE; ETORPHINE; NALTRINDOLE; NOCICEPTIN; OPIATE RECEPTOR;

ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; BINDING SITE; DRUG RECEPTOR BINDING; EXTRACELLULAR MATRIX; LIGAND BINDING; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN FAMILY; RAT; SITE DIRECTED MUTAGENESIS; STRUCTURE ACTIVITY RELATION;

EID: 0031957510     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: 10.1124/mol.53.4.772     Document Type: Article

References (40)

1. 35S]GTPγS binding: A tool to evaluate functional activity of a cloned opioid receptor transiently expressed in COS cells. Neurochem Res 21:1301-1307.
2. Blume AJ (1978) Interaction of ligands with the opiate receptor of brain membranes: Regulation by ions and nucleotides. Proc Natl Acad Sci USA 75:1713-1717.
3. Bunzow JR, Saez C, Mortrud M, Bouvier C, Williams JT, Low M, and Grandy DK (1994) Molecular cloning and tissue distribution of a putative member of the rat opioid receptor gene family that is not μ, δ, or κ opioid receptor type. FEBS Lett 347:284-288.
4. Chen C and Okayama H (1987) High-efficiency transformation of mammalian cells by plasmid DNA. Mol Cell Biol 7:2745-2752.
5. Chen Y, Fan Y, Liu J, Mestek A, Tian M, Kozak CA, and Yu L (1994) Molecular cloning, tissue distribution and chromosomal localization of a novel member of the opioid receptor gene family. FEBS Lett 347:279-283.
6. De Len A, Stadel JM, and Lefkowitz RJ (1980) A ternary complex model explains the agonist-specific binding properties of the adenylate cyclase-coupled β-adrenergic receptor. J Biol Chem 255:7108-7117.
7. de Vos AM, Ultsch M, and Kossiakoff AA (1992) Human growth hormone and extracellular domain of its receptor crystal structure of the complex. Science (Washington DC) 255:306-312.
8. Deng WP and Nickoloff JA (1991) Site-directed mutagenesis of virtually any plasmid by eliminating a unique site. Anal Biochem 200:81-88.
9. Devine DP, Reinscheid RK, Monsma FJ, Civelli O, and Akil H (1996a) The novel neuropeptide orphanin FQ fails to produce conditioned place preference or aversion. Brain Res 727:225-229.
10. Devine DP, Reinscheid RK, Monsma FJ, Civelli O, and Akil H (1996b) Rats rapidly develop tolerance to the locomotor-inhibiting effects of the novel neuropeptide orphanin FQ. Neurochem Res 21:1387-1396.
11. Dooley CT and Houghten RA (1996) Orphanin FQ: Receptor binding and analog structure activity relationships in rat brain. Life Sci 59:PL23-9.
12. 6 glioma cell line expressing the μ opioid receptor. J Pharmacol Exp Ther 278:1121-1127.
13. Fukuda K, Kato S, Mon K, Nishi M, Takeshima H, Iwabe N, Miyata T, Houtani T, and Sugimoto T (1994) cDNA cloning and regional distribution of a novel member of the opioid receptor family. FEBS Lett 343:42-46.
14. Hjorth SA, Thirstrup K, Grandy DK, and Schwartz TW (1995) Analysis of selective binding epitopes for the κ-opioid receptor antagonist nor-binaltorphimine. Mol Pharmacol 47:1089-1094.
15. Huggenvik JI, Collard MW, Stofko RE, Seasholtz AF, and Uhler MD (1991) Regulation of the human enkephalin promoter by two isoforms of the catalytic subunit of cyclic adenosine 3′,5′ -monophosphate-dependent protein kinase. Mol Endocrinol 5:921-930.
16. Kenakin T (1995) Agonist-receptor efficacy. I. Mechanisms of efficacy and receptor promiscuity. Trends Pharmacol Sci 16:188-192.
17. Kong H, Raynor K, Yasuda K, Moe ST, Portoghese PS, Bell GI, and Reisine T (1993) A single residue, aspartic acid 95, in the delta opioid receptor specifies selective high affinity agonist binding. J Biol Chem 268:23055-23058.
18. Lachowicz JE, Shen Y, Monsma FJJ, and Sibley DR (1995) Molecular cloning of a novel G protein-coupled receptor related to the opiate receptor family. J Neurochem 64:34-40.
19. Li X, Varga EV, Stropova D, Zalewska T, Malatynska E, Knapp RJ, Roeske WR, and Yamamura HI (1996) Delta-opioid receptor: The third extracellular loop determines naltrindole selectivity. Eur J Pharmacol 300;R1-R2.
20. 2 receptor. Eur J Pharmacol 227:205-214.
21. Meng F, Hoversten M, Thompson RC, Taylor L, Watson SJ, and Akil H (1995) A chimeric study of the molecular basis of affinity and selectivity of the κ and the δ opioid receptors: Potential role of extracellular domains. J Biol Chem 270:12730-12736.
22. Meng F, Taylor LP, Hoversten MT, Ueda Y, Ardati A, Reinscheid RK, Monsma FJ, Watson SJ, Civelli O, and Akil H (1996a) Moving from the orphanin FQ receptor to an opioid receptor using four point mutations. J Biol Chem 271:32016-32020.
23. Meng F, Ueda Y, Hoversten MT, Thompson RC, Taylor L, Watson SJ, and Akil H (1996b) Mapping the receptor domains critical for the binding selectivity of δ opioid ligands. Eur J Pharmacol 311:285-292.
24. Meunier J-C, Mollereau C, Toll L, Suaudeau C, Moisand C, Alvinerie P, Butour J-L, Guillemot J-C, Ferrara P, Monsarrat B, Mazarguil H, Vassart G, Parmentier M, and Costentin J (1995) Isolation and structure of the endogenous agonist of opioid receptor-like ORL1 receptor. Nature 377:532-535.
25. Mollereau C, Parmentier M, Mailleux P, Butour JL, Moisand C, Chalon P, Caput D, Vassart G, and C. MJ (1994) ORL1, a novel member of the opioid receptor family: Cloning, functional expression and localization. FEBS Lett 341:33-38.
26. Munson PJ and Rodbard D (1980) Ligand: A versatile computerized approach for characterization of ligand-binding systems. Anal Biochem 107:220-239.
27. Naidu A and Goldstein A (1989) Multiple opioid receptors: Ligand selectivity profiles and binding site signatures. Mol Pharmacol 36:265-272.
28. Nothacker HP, Reinscheid RK, Mansour A, Henningsen RA, Ardati A, Monsma FJ, Watson SJ, and Civelli O (1996) Primary structure and tissue distribution of the orphanin FQ precursor. Proc Natl Acad Sci USA 93:8677-8682.
29. Onogi T, Minami M, Katao Y, Nakagawa T, Aoki Y, Toya T, Katsumata S, and Satoh M (1995) DAMGO, a μ-opioid receptor selective agonist, distinguishes between μ-and δ-opioid receptors around their first extracellular loops. FEBS Lett 357:93-97.
30. 3-related opioid receptor. Mol Pharmacol 47: 1180-1188.
31. Reinscheid RK, Ardati A, Frederick J, Monsma FJ, and Civelli O (1996) Structure-activity relationship studies on the novel neuropeptide orphanin FQ. J Biol Chem 271:14163-14168.
32. Reinscheid RK, Nothacker H-P, Bourson A, Ardati A, Henningsen RA, Bunzow JR, Grandy DK, Langen H, Monsma FJ, and Civelli O (1995) Orphanin FQ, a neuropeptide that activates an opioidlike G protein-coupled receptor. Science (Washington DC) 270:792-794.
33. Schwartz TW (1994) Locating ligand-binding sites in 7TM receptors by protein engineering. Curr Opin Biotechnol 5:434-444.
34. Surratt CK, Johnson PS, Moriwaki A, Seidleck BK, Blaschak CJ, Wang JB, and Uhl GR (1994) Mu opiate receptor: Charged transmembrane domain amino acids are critical for agonist recognition and intrinsic activity. J Biol Chem 269:20548-20553.
35. Wang JB, Johnson PS, Imai I, Persico AM, Ozenberger BA, Eppler CM, and Uhl GR (1994a) cDNA cloning of an orphan opiate receptor gene family member and its splice variant. FEES Lett 348:75-79.
36. Wang JB, Johnson PS, Wu JM, Wang WF, and Uhl GR (1994b) Human K opiate receptor second extracellular loop elevates dynorphin's affinity for μ/κ chimeras. J Biol Chem 269:25966-25969.
37. Wang WW, Shahrestanifar M, Jin J, and Howells RD (1996) Studies on μ. and δ opioid receptor selectivity utilizing chimeric and site-mutagenized receptors. Proc Natl Acad Sci USA 92:12436-12440.
38. Watson B, Meng F, and Akil H (1996) A chimeric analysis of the opioid receptor domains critical for the binding selectivity of μ opioid ligands. Neurobiol Dis 3:87-96.
39. Wick MJ, Minnerath SR, Lin X, Elde R, Law PY, and Loh HH (1994) Isolation of a novel cDNA encoding a putative membrane receptor with high homology to the cloned μ, δ and κ opioid receptors. Mol Brain Res 27:37-44.
40. Xue JC, Chen C-G, Zhu JM, Kunapuli S, DeRiel JK, Lei Y, and Liu-Chen L-Y (1995) The third extracellular loop of the μ opioid receptor is important for agonist selectivity. J Biol Chem 269:12977-12979.